Chemicals · Founded 2002 · www.fineorganics.com · BSE 541557 · NSE FINEORG · ISIN INE686Y01026
No Notes Added Yet
Business
Fine Organic Industries Ltd. is a leading Indian manufacturer of specialty additives for various industries, primarily focusing on oleochemical-based additives. The company develops, produces, and markets a wide range of additives derived from natural fats and oils. Its core business model involves leveraging its R&D capabilities to create specialized products that enhance the properties of end-user materials. Fine Organic makes money by selling these high-value specialty additives to global and domestic customers across food, plastics, cosmetics, textiles, and other industrial applications.
Revenue Mix
Fine Organic Industries operates largely as a single segment, specializing in oleochemical-based additives. However, its products cater to several distinct end-user industries:
Food Additives: Emulsifiers, anti-staling agents, release agents, and nutritional supplements for baked goods, confectionery, dairy, and processed foods.
Polymer Additives: Slip agents, anti-fogging agents, mold release agents, and antistatic agents for various plastic applications including packaging films, automotive parts, and consumer goods.
Cosmetic & Personal Care Additives: Emollients, thickening agents, and conditioning agents for skincare, haircare, and oral care products.
Other Industrial Applications: Additives for textiles, coatings, lubricants, and rubber processing.
While precise revenue contribution percentages for each segment are not typically disclosed, food and polymer additives generally form the largest portions of their revenue mix.
Industry
Fine Organic operates in the specialty chemicals industry, a sector characterized by high R&D intensity, application-specific products, technical support, and often requires specific certifications. The company is particularly positioned in the niche segment of oleochemical-based additives, which are derived from natural, renewable resources. Within India, Fine Organic is one of the largest manufacturers in this specific domain and holds a significant global presence, particularly for certain food and polymer additives. It competes with both domestic and international specialty chemical players, often differentiating itself through product quality, customization capabilities, and adherence to global regulatory standards.
MOAT
Niche Specialization & R&D: Deep expertise in oleochemical-based additives, supported by strong in-house R&D capabilities, allows for new product development and customization, creating technical barriers to entry.
Global Certifications & Approvals: Extensive range of products compliant with stringent global food safety (e.g., USFDA, EU) and environmental regulations provides a significant competitive edge and enables access to international markets.
Long-standing Customer Relationships: Decades-long relationships with major domestic and international customers, built on consistent quality, technical support, and reliability.
Backward Integration & Scale: Some degree of backward integration into raw materials and efficient large-scale manufacturing processes in certain product lines contribute to cost competitiveness and reliability of supply.
High Switching Costs: For critical additives, customers often face high costs and risks associated with switching suppliers due to product reformulation, re-certification, and extensive testing requirements.
Growth Drivers
Increasing Demand for Processed Foods: Growing global population, urbanization, and changing lifestyles drive demand for packaged and processed foods, increasing the need for food additives.
Growth in Polymer Industry: Expansion of the plastics industry (packaging, automotive, infrastructure) in both domestic and international markets fuels demand for polymer additives.
Import Substitution & "Make in India": Government initiatives and a focus on domestic manufacturing encourage local sourcing of specialty chemicals, benefiting Fine Organic.
New Product Development & Application Expansion: Continuous R&D efforts to develop new additives and find new applications for existing products can open up new revenue streams.
Capacity Expansion: Strategic capacity expansions to meet rising demand and capture market share.
Export Opportunities: Strong global demand for their niche products allows for continued growth in international markets.
Risks
Raw Material Price Volatility: Key raw materials (e.g., palm oil, castor oil, other agricultural commodities) are subject to price fluctuations influenced by weather, geopolitical events, and demand-supply dynamics, impacting margins.
Regulatory Changes: Stricter environmental, health, and safety regulations globally for chemicals can lead to increased compliance costs or product obsolescence.
Competition: Intense competition from domestic and international specialty chemical manufacturers, potentially leading to pricing pressure.
Economic Slowdown: A downturn in global or domestic economies can reduce demand from end-user industries (food, plastics, cosmetics).
Foreign Exchange Fluctuations: A significant portion of revenue comes from exports and raw materials are often imported, exposing the company to currency volatility.
Technological Obsolescence: While specialized, new technologies or alternative products could emerge that diminish the relevance of existing additive types.
Management & Ownership
Fine Organic Industries is a professionally managed company with a strong promoter group. The company was founded by the Gandhi and Mirani families, who continue to hold significant stakes and actively participate in its management. Mr. Prakash Kumar Gandhi and Mr. Mukesh Gandhi, along with Mr. Jayen Mirani, are key figures in the leadership team, bringing decades of experience in the specialty chemicals sector. The management team has a long track record in the industry, focusing on R&D, quality, and global expansion. As of the latest available information, the promoter and promoter group typically hold a substantial majority stake, indicating high promoter commitment.
Outlook
Fine Organic Industries holds a strong position in the niche oleochemical-based specialty additives market, benefiting from increasing demand across its diverse end-user industries like food, plastics, and personal care. Its focus on R&D, global certifications, and long-standing customer relationships provide a durable competitive advantage. The company is well-poised to capitalize on trends such as growth in processed foods, the expanding polymer industry, and global demand for high-quality, specialized additives. However, the business is susceptible to volatility in agricultural commodity prices, which can impact margins. Furthermore, intense competition and evolving regulatory landscapes in key markets present ongoing challenges. While the long-term outlook appears positive due to secular growth trends in its addressable markets and strong operational capabilities, managing raw material costs and navigating competitive pressures will be crucial for sustained performance.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 488 | 547 | 550 | 596 | 517 | 607 | 588 | 597 | 555 | 625 |
| Other Income | 17 | 23 | 25 | 22 | 25 | 26 | 40 | 21 | 21 | 35 |
| Total Income | 506 | 570 | 574 | 618 | 542 | 633 | 628 | 618 | 576 | 660 |
| Total Expenditure | 370 | 403 | 410 | 445 | 414 | 487 | 465 | 462 | 460 | 495 |
| Operating Profit | 136 | 166 | 164 | 173 | 128 | 145 | 163 | 156 | 115 | 164 |
| Interest | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 3 |
| Depreciation | 15 | 15 | 12 | 13 | 13 | 15 | 12 | 13 | 14 | 18 |
| Exceptional Income / Expenses | 0 | -1 | 0 | 0 | 0 | 0 | 7 | 0 | 0 | 0 |
| Profit Before Tax | 120 | 150 | 152 | 160 | 115 | 130 | 158 | 143 | 101 | 144 |
| Provision for Tax | 25 | 35 | 38 | 42 | 32 | 33 | 40 | 33 | 27 | 25 |
| Profit After Tax | 95 | 115 | 114 | 118 | 83 | 97 | 118 | 110 | 74 | 118 |
| Adjustments | -1 | -0 | -0 | -0 | -0 | 0 | -1 | -1 | -0 | -1 |
| Profit After Adjustments | 94 | 115 | 113 | 117 | 83 | 97 | 117 | 109 | 74 | 117 |
| Adjusted Earnings Per Share | 30.7 | 37.4 | 36.9 | 38.3 | 27 | 31.7 | 38.2 | 35.4 | 24.1 | 38.3 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 615 | 660 | 779 | 856 | 1060 | 1038 | 1133 | 1876 | 3023 | 2123 | 2269 | 2365 |
| Other Income | 2 | 9 | 4 | 16 | 24 | 23 | 17 | 33 | 64 | 72 | 98 | 117 |
| Total Income | 617 | 669 | 783 | 872 | 1084 | 1061 | 1150 | 1909 | 3087 | 2195 | 2367 | 2482 |
| Total Expenditure | 501 | 514 | 634 | 697 | 827 | 798 | 934 | 1512 | 2192 | 1588 | 1756 | 1882 |
| Operating Profit | 116 | 155 | 149 | 174 | 258 | 264 | 216 | 397 | 895 | 606 | 610 | 598 |
| Interest | 8 | 8 | 4 | 3 | 6 | 8 | 6 | 5 | 5 | 2 | 2 | 4 |
| Depreciation | 23 | 30 | 24 | 20 | 17 | 35 | 47 | 40 | 48 | 57 | 52 | 57 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 7 |
| Profit Before Tax | 86 | 117 | 121 | 151 | 234 | 216 | 162 | 352 | 841 | 544 | 555 | 546 |
| Provision for Tax | 29 | 41 | 43 | 56 | 95 | 51 | 42 | 92 | 223 | 132 | 145 | 125 |
| Profit After Tax | 57 | 76 | 78 | 95 | 140 | 165 | 120 | 260 | 618 | 412 | 410 | 420 |
| Adjustments | 0 | 0 | 0 | 0 | -3 | -0 | -0 | -0 | 0 | 0 | 0 | -3 |
| Profit After Adjustments | 57 | 76 | 78 | 95 | 136 | 165 | 120 | 260 | 618 | 412 | 410 | 417 |
| Adjusted Earnings Per Share | 19.7 | 26.3 | 26.9 | 31.1 | 44.4 | 53.7 | 39.2 | 84.7 | 201.6 | 134.3 | 133.9 | 136 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 7% | 7% | 17% | 14% |
| Operating Profit CAGR | 1% | 15% | 18% | 18% |
| PAT CAGR | -0% | 16% | 20% | 22% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -1% | -0% | 10% | NA% |
| ROE Average | 19% | 31% | 28% | 29% |
| ROCE Average | 26% | 41% | 37% | 37% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 194 | 254 | 328 | 396 | 500 | 619 | 731 | 959 | 1541 | 1921 | 2295 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 55 | 52 | 0 | 0 | 93 | 91 | 57 | 25 | 0 | 0 | 0 |
| Other Non-Current Liabilities | -1 | -3 | -4 | -5 | 4 | 1 | -4 | -7 | -10 | -11 | -14 |
| Total Current Liabilities | 126 | 113 | 116 | 134 | 105 | 134 | 155 | 251 | 265 | 184 | 214 |
| Total Liabilities | 375 | 416 | 441 | 525 | 702 | 845 | 940 | 1228 | 1796 | 2094 | 2495 |
| Fixed Assets | 124 | 125 | 97 | 88 | 78 | 217 | 196 | 229 | 214 | 268 | 363 |
| Other Non-Current Assets | 41 | 40 | 63 | 103 | 190 | 104 | 123 | 110 | 162 | 143 | 319 |
| Total Current Assets | 210 | 251 | 281 | 333 | 434 | 524 | 620 | 888 | 1420 | 1682 | 1813 |
| Total Assets | 375 | 416 | 441 | 525 | 702 | 845 | 940 | 1228 | 1796 | 2094 | 2495 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 9 | 3 | 40 | 14 | 11 | 108 | 206 | 259 | 226 | 515 | 695 |
| Cash Flow from Operating Activities | 80 | 114 | 45 | 65 | 98 | 219 | 134 | 67 | 485 | 635 | 204 |
| Cash Flow from Investing Activities | -65 | -28 | -16 | -52 | -93 | -85 | -40 | -56 | -85 | -391 | -669 |
| Cash Flow from Financing Activities | -20 | -56 | -55 | -17 | 92 | -37 | -41 | -68 | -69 | -59 | -34 |
| Net Cash Inflow / Outflow | -6 | 30 | -26 | -3 | 97 | 98 | 53 | -58 | 332 | 185 | -499 |
| Closing Cash & Cash Equivalent | 3 | 44 | 14 | 11 | 108 | 206 | 259 | 226 | 515 | 695 | 189 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 19.69 | 26.29 | 26.87 | 31.09 | 44.43 | 53.74 | 39.24 | 84.67 | 201.6 | 134.34 | 133.89 |
| CEPS(Rs) | 27.51 | 36.58 | 35.05 | 37.63 | 51.23 | 65.05 | 54.5 | 97.72 | 217.22 | 152.8 | 150.94 |
| DPS(Rs) | 15 | 22.5 | 22.5 | 7 | 7 | 7 | 11 | 9 | 9 | 10 | 11 |
| Book NAV/Share(Rs) | 66.83 | 87.7 | 113.2 | 129.02 | 163.16 | 201.86 | 238.55 | 312.85 | 502.69 | 625.99 | 748.61 |
| Core EBITDA Margin(%) | 17.7 | 21.04 | 17.76 | 18.25 | 21.98 | 23.08 | 17.55 | 19.27 | 27.45 | 25.09 | 22.58 |
| EBIT Margin(%) | 14.49 | 18.05 | 15.34 | 17.78 | 22.6 | 21.51 | 14.82 | 18.84 | 27.93 | 25.66 | 24.53 |
| Pre Tax Margin(%) | 13.3 | 16.85 | 14.81 | 17.41 | 22.03 | 20.74 | 14.28 | 18.58 | 27.78 | 25.54 | 24.44 |
| PAT Margin (%) | 8.86 | 10.99 | 9.54 | 10.98 | 13.14 | 15.82 | 10.6 | 13.73 | 20.42 | 19.34 | 18.07 |
| Cash Profit Margin (%) | 12.38 | 15.29 | 12.45 | 13.29 | 14.78 | 19.14 | 14.72 | 15.84 | 22 | 21.99 | 20.37 |
| ROA(%) | 15.97 | 19.28 | 18.18 | 19.74 | 22.75 | 21.3 | 13.48 | 23.96 | 40.88 | 21.17 | 17.89 |
| ROE(%) | 32.34 | 34.03 | 26.75 | 26.35 | 31.17 | 29.45 | 17.82 | 30.72 | 49.44 | 23.81 | 19.48 |
| ROCE(%) | 32.87 | 38.33 | 34.53 | 37.75 | 44.57 | 32.67 | 21.52 | 38.78 | 65.39 | 31.34 | 26.45 |
| Receivable days | 46.98 | 46.84 | 44.54 | 54 | 51.88 | 50.43 | 47.24 | 44.67 | 39.3 | 56.71 | 51.64 |
| Inventory Days | 33.66 | 37.02 | 37.66 | 38.11 | 30.64 | 38.7 | 41.44 | 34.9 | 41.03 | 60.47 | 50.11 |
| Payable days | 54.85 | 51.77 | 44.21 | 45.19 | 35.82 | 43.41 | 47.86 | 39.94 | 34.62 | 48.24 | 41.45 |
| PER(x) | 0 | 0 | 0 | 0 | 27.83 | 35.39 | 58.17 | 47.41 | 21.36 | 30 | 29.83 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 7.58 | 9.42 | 9.57 | 12.83 | 8.57 | 6.44 | 5.34 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0.57 | 0.37 | 0.48 | 0.22 | 0.21 | 0.25 | 0.28 |
| EV/Net Sales(x) | 0.17 | 0.1 | 0.03 | 0.07 | 3.59 | 5.53 | 6.02 | 6.47 | 4.2 | 5.33 | 4.98 |
| EV/Core EBITDA(x) | 0.9 | 0.41 | 0.18 | 0.32 | 14.79 | 21.78 | 31.54 | 30.54 | 14.2 | 18.65 | 18.51 |
| Net Sales Growth(%) | 8.38 | 7.32 | 18.1 | 9.84 | 23.9 | -2.1 | 9.16 | 65.57 | 61.12 | -29.78 | 6.89 |
| EBIT Growth(%) | -11.21 | 34.09 | 0.04 | 23.29 | 55.62 | -6.7 | -24.91 | 111.83 | 137.2 | -35.36 | 1.98 |
| PAT Growth(%) | -7.56 | 33.49 | 2.21 | 22.41 | 46.45 | 18.05 | -26.98 | 115.81 | 138 | -33.36 | -0.34 |
| EPS Growth(%) | -7.56 | 33.49 | 2.21 | 15.71 | 42.9 | 20.96 | -26.98 | 115.76 | 138.09 | -33.36 | -0.34 |
| Debt/Equity(x) | 0.53 | 0.4 | 0.12 | 0.14 | 0.26 | 0.2 | 0.12 | 0.06 | 0.02 | 0 | 0 |
| Current Ratio(x) | 1.66 | 2.22 | 2.41 | 2.48 | 4.12 | 3.91 | 4 | 3.54 | 5.37 | 9.13 | 8.46 |
| Quick Ratio(x) | 1.15 | 1.55 | 1.62 | 1.82 | 3.27 | 2.93 | 3.19 | 2.6 | 3.69 | 7.71 | 6.76 |
| Interest Cover(x) | 12.12 | 15.06 | 28.52 | 48.93 | 39.62 | 28.08 | 27.45 | 72.14 | 185.11 | 224.64 | 253.85 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0.03 | 0.02 | 0.01 | 0 | 0 | 0 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 3.59 | 4.47 | 4.94 | 4.89 | 5.22 | 4.66 | 4.81 | 4.57 | 4.43 | 4.4 |
| DII | 11.85 | 10.76 | 11.13 | 11.57 | 11.52 | 12.04 | 11.94 | 12.02 | 11.8 | 11.65 |
| Public | 9.57 | 9.77 | 8.93 | 8.55 | 8.26 | 8.31 | 8.26 | 8.41 | 8.77 | 8.95 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 |
| FII | 0.11 | 0.14 | 0.15 | 0.15 | 0.16 | 0.14 | 0.15 | 0.14 | 0.14 | 0.13 |
| DII | 0.36 | 0.33 | 0.34 | 0.35 | 0.35 | 0.37 | 0.37 | 0.37 | 0.36 | 0.36 |
| Public | 0.29 | 0.3 | 0.27 | 0.26 | 0.25 | 0.25 | 0.25 | 0.26 | 0.27 | 0.27 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +7% | +7% | +17% | +14% |
| Operating Profit CAGR | +1% | +15% | +18% | +18% |
| PAT CAGR | 0% | +16% | +20% | +22% |
| Share Price CAGR | -1% | 0% | +10% | — |
| ROE Average | +19% | +31% | +28% | +29% |
| ROCE Average | +26% | +41% | +37% | +37% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 3.59 | 4.47 | 4.94 | 4.89 | 5.22 | 4.66 | 4.81 | 4.57 | 4.43 | 4.4 |
| DII | 11.85 | 10.76 | 11.13 | 11.57 | 11.52 | 12.04 | 11.94 | 12.02 | 11.8 | 11.65 |
| Public | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 |
| FII | 0.11 | 0.14 | 0.15 | 0.15 | 0.16 | 0.14 | 0.15 | 0.14 | 0.14 | 0.13 |
| DII | 0.36 | 0.33 | 0.34 | 0.35 | 0.35 | 0.37 | 0.37 | 0.37 | 0.36 | 0.36 |
| Public | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 | 3.07 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.